| 521 |
LODOZ 2.5 MG/ 6.25 MG |
BISOPROLOL FUMARATE 2.50 MG, HYDROCHLOROTHIAZIDE 6.25 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
MILD TO MODERATE ESSENTIAL HYPERTENSION |
NULL |
DKSH LAOS COMPANY LIMITED |
MERCK HEALTHCARE KGaA |
FRANCE |
CERTIFICATE RELEASED |
12 I 5012/20 |
08-APR-2024 |
07-APR-2027 |
View |
| 522 |
LODOZ 5 MG/ 6.25 MG |
BISOPROLOL FUMARATE 5 MG, HYDROCHLOROTHIAZIDE 6.25 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
MILD TO MODERATE ESSENTIAL HYPERTENSION |
NULL |
DKSH LAOS COMPANY LIMITED |
MERCK HEALTHCARE KGaA |
FRANCE |
CERTIFICATE RELEASED |
12 I 5013/20 |
08-APR-2024 |
07-APR-2027 |
View |
| 523 |
LOPID |
GEMFIBROZIL 600 MG |
TABLET |
PVC-ALU BLISTER |
GEMFIBROZIL IS A LIPID REGULATIONG AGENT THAT IS INDICATED FOR THE FOLLOWING :
PRIMARY PREVENTION OF CORONARY HEART DISEASE (CHD) AND MYOCARDIAL INFARCTION (MI) IN PATIENTS WITH HYPERCHOLESTEROLEMIA, MIXED DYSLIPIDEMIA AND HYPERTRIGLYCERIDEMIA, FREDRICKSON'S CLASSIFICATION TYPES IIA, IIB AND IV. |
NULL |
DKSH LAOS COMPANY LIMITED |
OLIC (THAILAND) LIMITED |
THAILAND |
CERTIFICATE RELEASED |
11 I 3994/13 |
22-JUN-2024 |
21-JUN-2027 |
View |
| 524 |
LOPID |
GEMFIBROZIL 300 MG |
CAPSULE |
PVC-ALU BLISTER |
GEMFIBROZIL IS A LIPID REGULATIONG AGENT THAT IS INDICATED FOR THE FOLLOWING :
PRIMARY PREVENTION OF CORONARY HEART DISEASE (CHD) AND MYOCARDIAL INFARCTION (MI) IN PATIENTS WITH HYPERCHOLESTEROLEMIA, MIXED DYSLIPIDEMIA AND HYPERTRIGLYCERIDEMIA, FREDRICKSON'S CLASSIFICATION TYPES IIA, IIB AND IV. |
NULL |
DKSH LAOS COMPANY LIMITED |
OLIC (THAILAND) LIMITED |
THAILAND |
CERTIFICATE RELEASED |
07 I 4016/14 |
22-JUN-2024 |
21-JUN-2027 |
View |
| 525 |
MEBENEX 500 |
MEBENDAZOLE USP 500 MG |
CHEWABLE TABLET |
ALU/ALU BLISTER |
USED FOR THE TREATMENT OF TRICHURIS TRICHURIA, ENTEROBIUS VERMICULARIS, ASCARIS LUMBRICOIDES, ANCYLOSTOMA DUODENALE, NECATOR AMERICANUS IN SINGLE OR MIXED GASTROINTESTINAL INFESTATION |
NULL |
DKSH LAOS COMPANY LIMITED |
COTEC HEALTHCARE PVT LTD |
INDIA |
CERTIFICATE RELEASED |
10 I 5308/22 |
11-NOV-2022 |
10-NOV-2025 |
View |
| 526 |
MEC 500 |
METHYLCOBALAMIN 500 MCG |
FILM COATED TABLET |
ALU-ALU BLISTER PACK |
PERIPHERAL NEUROPATHIES, TREATMENT OF NUTRITIONAL VITAMIN B12 DEFICIENCY, TREATMENT OF VITAMIN B12 DEFICIENCY FOLLOWING PARTIAL GASTRECTOMY, TREATMENT OF TROPICAL SPRUE ALONE OR WITH FOLIC ACID, TREATMENT OF PERNICIOUS ANEMIA WHEN PARENTERAL ADMINISTRATION IS NOT POSSIBLE OR ADVISED |
NULL |
DKSH LAOS COMPANY LIMITED |
COTEC HEALTHCARE PVT LTD |
INDIA |
CERTIFICATE RELEASED |
12 I 5344/22 |
30-DEC-2022 |
29-DEC-2025 |
View |
| 527 |
MERISLON 6 MG |
BETAHISTINE MESILATE 6MG |
TABLET |
strip |
VERTIGO AND DIZZINESS ASSOCIATED WITH THE FOLLOWING DISEASES: MENIERE'S DISEASE, MENIERE'S SYNDROME, PERIPHERAL VERTIGO |
NULL |
DKSH LAOS COMPANY LIMITED |
INTERTHAI PHARMMACEUTICAL MANUFACTURIN LTD |
THAILAND |
CERTIFICATE RELEASED |
01 I 2868/07 |
19-MAY-2023 |
18-MAY-2026 |
View |
| 528 |
METFORMIN 1000 MG |
METFORMIN HYDROCHLORIDE 1000 MG |
FILM COATED TABLET |
PVC/ALU BLISTER |
TREATMENT OF TYPE 2 DIABETES MELLITUS, PARTICULARLY IN OVERWEIGHT PATIENTS WHEN DIETARY MANAGEMENT AND EXCERCISE ALONE DOES NOT RESULT IN ADEQUATE GLYCAEMIC CONTROL |
NULL |
DKSH LAOS COMPANY LIMITED |
LEK S.A |
AUSTRIA |
CERTIFICATE RELEASED |
07 I 5257/22 |
17-Aug-2022 |
16-Aug-2025 |
View |
| 529 |
METFORWAN XR 1000 |
METFORMIN HYDROCHLORIDE USP 1000 MG |
EXTENED RELEASE TABLET |
ALU-ALU BLISTER PACK |
TREATMENT OF TYPE 2 DIABETES ME;;ITUS, PARTICULARLY IN OVERWEIGHT PATIENTS, WHEN DIETARY MANAGEMENT AND EXCERCISE ALONE DOES NOT RESULT IN ADEQUATE GLYCAEMIC CONTROL |
NULL |
DKSH LAOS COMPANY LIMITED |
ARGON REMEDIES PVT.LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5667/24 |
26-JAN-2024 |
25-JAN-2027 |
View |
| 530 |
METFORWAN XR 500 |
METFORMIN HYDROCHLORIDE USP 500 MG |
EXTENED RELEASE TABLET |
ALU-ALU BLISTER PACK |
TREATMENT OF TYPE 2 DIABETES ME;;ITUS, PARTICULARLY IN OVERWEIGHT PATIENTS, WHEN DIETARY MANAGEMENT AND EXCERCISE ALONE DOES NOT RESULT IN ADEQUATE GLYCAEMIC CONTROL |
NULL |
DKSH LAOS COMPANY LIMITED |
ARGON REMEDIES PVT.LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5668/24 |
26-JAN-2024 |
25-JAN-2027 |
View |
